1.Clinicopathological analysis of 39 cases with primary fallopian tube cancer
Chengxiang NI ; Jing WEN ; Xingzhi CHU ; Chan XU ; Jianjun ZHAI
Practical Oncology Journal 2017;31(4):335-341
Objective The objective of this study was to investigate the clinicopathological features and rational treatment of primary fallopian tube cancer(PFTC).Methods The clinical and pathological data of 39 patients with primary fallopian tube cancer from January 2006 to July 2016 in Beijing Tongren Hospital of Capital University were retrospectively analyzed.Results There were 39 cases of undifferentiated carcinoma,including 1 case of undifferentiated and transitional cell carcinoma,37 cases of undifferentiated adenocarcinoma,or 29 cases of simple adenocarcinoma and 10 cases of mixed type.Among them,7 cases were treated with clear cell carcinoma,endometriosis in 2 cases,combined with transitional cell carcinoma in 1 case.Extra-pelvic metastases were the most common site of the omentum with 17 cases.The preoperative test CA125 was increased in 13 cases and 38 patients received postoperative chemotherapy.The 5-year overall survival rate of 39 patients was 51.3%.Univariate analysis showed that postoperative pathologic stage(Ⅰ~Ⅱ vs.Ⅲ,P<0.001),intraoperative residual lesion size(P<0.001),omentum metastasis(P<0.001),ovarian metastasis(P=0.034),retroperitoneal lymph node metastasis(P=0.018)and preoperative CA125 elevation(P=0.002)were associated with prognosis,while age(P=0.310)and pathological grade(P=0.663)were not associated with prognosis.Multivariate analysis showed that the number of patients with postoperative lymph node metastasis(P=0.018)and preoperative CA125 elevation(P=0.002)were correlated with prognosis(HR=1.202,95% CI:2.354~63.290,P=0.003) and pathological stage(HR=3.810,95% CI:1.202~12.079,P=0.023).They were associated with prognosis as independent prognostic factors.Conclusion Tumor pathologic staging and omentum metastasis are important prognostic factors influencing the prognosis of patients with primary fallopian tube cancer.Early diagnosis and complete operation can improve the prognosis of patients.
2.Novel cationic liposome loading siRNA inhibits the expression of hepatitis B virus HBx gene.
Yajuan WANG ; Yuqing GAO ; Beibei NI ; Chan LI ; Tianjiao WEN ; Yanling WANG ; Jia WANG ; Chunlei LI
Acta Pharmaceutica Sinica 2014;49(9):1326-30
In order to solve the problem of selection and in vivo delivery problem in siRNA treatment, hepatitis B virus (HBV) HBx gene which could be targeted by siRNA was studied. The siRNA expression plasmid which specific inhibits HBx expression was obtained by in vitro selection via a dual-luciferase plasmid including HBx-Fluc fusion protein expression domain. The selected siRNA expression plasmid was then encapsulated in PEG-modified cationic liposome, which was devoted into pharmacodynamic studies at both cellular and animal level. The results illustrated that the cationic liposome which encapsulated siRNA expression plasmid could effectively inhibit HBx gene expression both in vitro and in vivo.
3.Comparison of the therapeutic effect of preoperative and postoperative chemoradiotherapy for locally advanced rectal cancer
Chan CHENG ; Shan JIN ; Wen PENG ; Ying JIANG ; Xueying SI ; Wen LUO ; Tingting NI ; Shisheng TAN
Chongqing Medicine 2018;47(16):2173-2176,2180
Objective To compare the therapeutic effect of preoperative chemoradiotherapy or postoperative adjutant chemoradiotherapy for locally advanced rectal cancer.Methods The clinical data of 76 patients with locally advanced rectal cancer from 2011 to 2016 in Guizhou Provincial People's Hospital were retrospectively analysed.A total of 30 cases received preoperative chemoradiotherapy (group A),5 of them received concurrent chemoradiotherapy combined with bevacizumab target treatment.The other 46 cases (group B) were given post-operative adjutant chemoradiotherapy.Both group A and group B were treated with intensity-modulated radiation therapy (IMRT).The chemoradiotherapy regime was as follows:the median of target volume dose was 50.4 Gy (45.0-55.8 Gy);the median of chemotherapy sessions was 26 times (24-28 times).Capecitabine tablets (825 mg/m2,twice a day) were also given on the date of chemotherapy.The clinical data and follow-up results of all patients were compared between the two groups.Results The five-year disease free survival rates of group A and group B were 66.7% and 57.7%,respectively;and the five-year overall survival rates of group A and group B were 81.8% and 73.0%,respectively,no statistically significant difference was found between the two groups (P=0.599,0.489).The anus-preserving rates of patients with tumor below peritoneal reflection in group A and group B were 56.52% and 25.00%,there was statistically significant difference (P=0.045).In the group A,86.6 % patients resulted in down-staging,including 3 cases with complete pathologic response.Conclusion Preoperative chemotherapy could down tumor stage and improve rates of anal preservation and local control without increasing possibility of postoperative complications.Preoperative chemotherapy in combination with bevacizumab target treatment may be more effective in lowering tumor stage.
4.Novel cationic liposome loading siRNA inhibits the expression of hepatitis B virus HBx gene.
Ya-Juan WANG ; Yu-Qing GAO ; Bei-Bei NI ; Chan LI ; Tian-Jiao WEN ; Yan-Ling WANG ; Jia WANG ; Chun-Lei LI
Acta Pharmaceutica Sinica 2014;49(9):1326-1330
In order to solve the problem of selection and in vivo delivery problem in siRNA treatment, hepatitis B virus (HBV) HBx gene which could be targeted by siRNA was studied. The siRNA expression plasmid which specific inhibits HBx expression was obtained by in vitro selection via a dual-luciferase plasmid including HBx-Fluc fusion protein expression domain. The selected siRNA expression plasmid was then encapsulated in PEG-modified cationic liposome, which was devoted into pharmacodynamic studies at both cellular and animal level. The results illustrated that the cationic liposome which encapsulated siRNA expression plasmid could effectively inhibit HBx gene expression both in vitro and in vivo.
Cations
;
Gene Expression Regulation, Viral
;
drug effects
;
Hepatitis B virus
;
genetics
;
Liposomes
;
chemistry
;
Plasmids
;
RNA, Small Interfering
;
chemistry
;
Trans-Activators
;
genetics
;
metabolism
5.Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
Wen-Hui CHAN ; Pi-Ling CHIANG ; An-Ni LIN ; Yen-Hsiang CHANG ; Wei-Che LIN
Ultrasonography 2024;43(6):395-406
The diagnosis and management of Bethesda III and IV thyroid nodules remain clinical dilemmas. Current guidelines from academic societies suggest active surveillance or diagnostic lobectomy. However, the extent of surgery is often inappropriate, and a considerable percentage of patients experience under- or over-treatment. Thermal ablation has gained popularity as a safe and effective alternative treatment option for benign thyroid nodules. This review explores the feasibility of thermal ablation for Bethesda III or IV thyroid nodules, aiming to preserve the thyroid organ and avoid unnecessary surgery. It emphasizes individualized management, the need to consider factors including malignancy risk, clinical characteristics, and sonographic features, and the importance of supplemental tests such as repeat fine needle aspiration cytology, core needle biopsy, molecular testing, and radioisotope imaging.
6.Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
Wen-Hui CHAN ; Pi-Ling CHIANG ; An-Ni LIN ; Yen-Hsiang CHANG ; Wei-Che LIN
Ultrasonography 2024;43(6):395-406
The diagnosis and management of Bethesda III and IV thyroid nodules remain clinical dilemmas. Current guidelines from academic societies suggest active surveillance or diagnostic lobectomy. However, the extent of surgery is often inappropriate, and a considerable percentage of patients experience under- or over-treatment. Thermal ablation has gained popularity as a safe and effective alternative treatment option for benign thyroid nodules. This review explores the feasibility of thermal ablation for Bethesda III or IV thyroid nodules, aiming to preserve the thyroid organ and avoid unnecessary surgery. It emphasizes individualized management, the need to consider factors including malignancy risk, clinical characteristics, and sonographic features, and the importance of supplemental tests such as repeat fine needle aspiration cytology, core needle biopsy, molecular testing, and radioisotope imaging.
7.Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
Wen-Hui CHAN ; Pi-Ling CHIANG ; An-Ni LIN ; Yen-Hsiang CHANG ; Wei-Che LIN
Ultrasonography 2024;43(6):395-406
The diagnosis and management of Bethesda III and IV thyroid nodules remain clinical dilemmas. Current guidelines from academic societies suggest active surveillance or diagnostic lobectomy. However, the extent of surgery is often inappropriate, and a considerable percentage of patients experience under- or over-treatment. Thermal ablation has gained popularity as a safe and effective alternative treatment option for benign thyroid nodules. This review explores the feasibility of thermal ablation for Bethesda III or IV thyroid nodules, aiming to preserve the thyroid organ and avoid unnecessary surgery. It emphasizes individualized management, the need to consider factors including malignancy risk, clinical characteristics, and sonographic features, and the importance of supplemental tests such as repeat fine needle aspiration cytology, core needle biopsy, molecular testing, and radioisotope imaging.
8.Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
Wen-Hui CHAN ; Pi-Ling CHIANG ; An-Ni LIN ; Yen-Hsiang CHANG ; Wei-Che LIN
Ultrasonography 2024;43(6):395-406
The diagnosis and management of Bethesda III and IV thyroid nodules remain clinical dilemmas. Current guidelines from academic societies suggest active surveillance or diagnostic lobectomy. However, the extent of surgery is often inappropriate, and a considerable percentage of patients experience under- or over-treatment. Thermal ablation has gained popularity as a safe and effective alternative treatment option for benign thyroid nodules. This review explores the feasibility of thermal ablation for Bethesda III or IV thyroid nodules, aiming to preserve the thyroid organ and avoid unnecessary surgery. It emphasizes individualized management, the need to consider factors including malignancy risk, clinical characteristics, and sonographic features, and the importance of supplemental tests such as repeat fine needle aspiration cytology, core needle biopsy, molecular testing, and radioisotope imaging.
9.Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management
Wen-Hui CHAN ; Pi-Ling CHIANG ; An-Ni LIN ; Yen-Hsiang CHANG ; Wei-Che LIN
Ultrasonography 2024;43(6):395-406
The diagnosis and management of Bethesda III and IV thyroid nodules remain clinical dilemmas. Current guidelines from academic societies suggest active surveillance or diagnostic lobectomy. However, the extent of surgery is often inappropriate, and a considerable percentage of patients experience under- or over-treatment. Thermal ablation has gained popularity as a safe and effective alternative treatment option for benign thyroid nodules. This review explores the feasibility of thermal ablation for Bethesda III or IV thyroid nodules, aiming to preserve the thyroid organ and avoid unnecessary surgery. It emphasizes individualized management, the need to consider factors including malignancy risk, clinical characteristics, and sonographic features, and the importance of supplemental tests such as repeat fine needle aspiration cytology, core needle biopsy, molecular testing, and radioisotope imaging.
10.Relaxed effect of Cynomorium songaricum Rupr and its active ingredients on detrusor muscle strip tension in rats
Xiao-Ting YUN ; Zhi-Qian WANG ; Wen-Zhang ZHOU ; Er-Wei LIU ; Rui TAO ; Lin MIAO ; Chan-Yuan JIAO ; Xue-Ni WANG
The Chinese Journal of Clinical Pharmacology 2017;33(19):1938-1941
Objective To study the relaxed effect of Cynomorium songaricum Rupr (CS) on the detrusor muscle strip tension in rats.Methods Detrusor muscle strips of rats were isolated.The effects of the CS extract and its active ingredients on the potassium chloride (KCl) or acetylcholine (Ach) induced-contraction of detrusor muscle strip were investigated in vitro respectively.Results Both KCl and Achsignificantly induced spontaneous contraction of bladder detrusor muscle strips,and CS extract inhibited both KCl and Ach-induced contraction in a dose-dependent manner.The maximum relaxation ratios of CS in response to KCl and Ach were (23.34 ± 2.40) % and (25.42 ± 5.53) % respectively at the concentration of 1 × 10-2g · mL-1.Its active ingredient Luteolin (LUT),Epicatechin (EPI) and Epigallocatechin gallate (ECG) also inhibited KCl-induced contraction of bladder detrusor muscle strips,and the relaxation ratios were (19.31 ±7.19)%,(19.03 ±6.86)% and (21.22 ± 10.89) %,respectively.Conclusion CS could relieve detrusor tension in bladder,in which LUT,EPI and ECG are involved.